To date, the role of PPARγ in the gastrointestinal tract has, in the main, been restricted to the study of inflammation and cancer, which has led to the identification of PPARγ as a promising therapeutic target in colon cancer. This evidence concerns the gene PPARG and colonic neoplasm.